Akita H, Mukai Y, Kubo M, Takahashi H, et al. A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable and borderline resectable pancreatic cancer. Surgery 2024 Jul 29:S0039-6060(24)00473-2. doi: 10.1016/j.surg.2024.
PMID: 39079828